HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nina Skuban Selected Research

Fabry Disease (Fabry's Disease)

12/2021Corrigendum to "Long-term follow-up of renal function in patients treated with migalastat for Fabry disease" [Bichet et al., MGM Reports; 28 (2021) 100786].
10/2021FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.
9/2021Long-term follow-up of renal function in patients treated with migalastat for Fabry disease.
1/2021Correction: Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease.
1/2021Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease.
9/2020Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study.
2/2020Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study.
1/2019Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report.
1/2019Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
1/2019Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nina Skuban Research Topics

Disease

13Fabry Disease (Fabry's Disease)
12/2021 - 08/2016
3Psychotic Disorders (Schizoaffective Disorder)
04/2012 - 02/2010
2Diarrhea
01/2019 - 01/2018
2Hyponatremia
04/2012 - 03/2010
1Pain (Aches)
01/2021
1Hypertension (High Blood Pressure)
01/2019
1Proteinuria
01/2019
1Epilepsy (Aura)
01/2002
1Nervous System Diseases (Neurological Disorders)
01/2002

Drug/Important Bio-Agent (IBA)

12migalastatIBA
12/2021 - 08/2016
2globotriaosyl lysosphingolipidIBA
01/2021 - 01/2021
2globotriaosylceramide (globotriosylceramide)IBA
01/2019 - 01/2018
2GalactosidasesIBA
01/2017 - 08/2016
2TolvaptanFDA Link
04/2012 - 03/2010
2SodiumIBA
04/2012 - 03/2010
1EnzymesIBA
10/2021
1alpha-Galactosidase (Beano)IBA
10/2021
1larazotide acetateIBA
09/2020
1Biomarkers (Surrogate Marker)IBA
01/2018
1Antidiuretic Hormone Receptor AntagonistsIBA
04/2012
1Antipsychotic Agents (Antipsychotics)IBA
02/2010
1Aripiprazole (Abilify)FDA Link
02/2010
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2002

Therapy/Procedure

4Enzyme Replacement Therapy
09/2021 - 01/2017